Effect Of Glucagon on Treatment Of Acute Severe Asthma Attack

Phase 3

Recruiting

• Conditions: Asthma.; Asthma

• Registration Number: IRCT20131118015446N13
• Lead Sponsor: Ahvaz Jundishapur University Of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Severe asthma attack
Age between 18 and 55

Exclusion Criteria

History of diabetes mellitus
Smoking
Ischemic heart disease
Emphysema or chronic bronchitis
Insulinoma
pheochromocytoma
Current oral or injectable corticosteroids, pregnancy
Pregnancy
Lactation
Need for intubation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peak Expiratory Flow Rate (PEFR). Timepoint: At 0, 10, 15, 30, 45 ,60 minutes after intervention. Method of measurement: Litre/minute, by spirometry.;FEV1. Timepoint: At 0, 10, 15, 30, 45 ,60 minutes after intervention. Method of measurement: Litre, by spirometry.

Secondary Outcome Measures

Name	Time	Method
Respiratory rate. Timepoint: At 0 and 60 minutes after intervention. Method of measurement: Counting of respiration in one minute.;Pulse rate. Timepoint: At 0 and 60 minutes after intervention. Method of measurement: Counting of pulse in one minute.;Blood pressure. Timepoint: At 0 and 60 minutes after intervention. Method of measurement: mmHg, by sphygmomanometer.;Blood glucose. Timepoint: At 0 and 20 minutes after intervention. Method of measurement: mg/dL, by glucometer.;Blood oxygen saturation levels (SpO2). Timepoint: At 0 and 60 minutes after intervention. Method of measurement: Percentage, by pulse oximeter.